Uterine fibroids are the most common clinical findings associated with females in the reproductive age group. Early detection and treatment planning may result in a safe outcome for the victim; otherwise, the outcome may be fatal or complicated. Some techniques are already available, such as surgery, etc., but Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) is a new era in medical science that is being used to treat tumours like uterine fibroids and others. Currently, Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) is widely used to treat uterine lesions, but it can be used for other lesions as well. There is no need to admit the patient for this procedure. MRgFUS has become a popular choice of non-invasive treatment tools for both benign and malignant tumours. MRgFUS is also approved by the US Food and Drug Administration (FDA) for uterine fibroid treatment.